Packaging Artwork Approval Process in Pharma & Medical Devices
Table of contents
- Introduction
- What is artwork for labeling and packaging?
- Artwork is about safety and compliance
- Artwork for medical devices
- Who is involved?
- Parallel approvals and multiple projects
- Collaboration and integration of software
- TVT supports the labeling and packaging workflows
- What you can expect from TVT
- References
Improve artwork approval processes to reduce risk and protect patients
Improving artwork approval processes in pharmaceutical and medical device companies is not just about efficiency, it directly impacts patient safety and business performance.
Artwork approval workflows must be both accurate and efficient, yet they are often complex. Multiple departments are involved, timelines are tight, and the stakes are high.
When done well, a structured artwork approval process helps organizations:
- Ensure compliance with cGMP and regulatory requirements
- Support successful product submissions
- Accelerate time to market
- Reduce the risk of costly recalls
- Protect patient safety
This is especially critical in an industry where bringing a product to market can exceed $1 billion in investment.
What is artwork for labeling and packaging?
Labeling and packaging artwork refers to the visual design and layout of product information.
This includes:
- Primary packaging (in direct contact with the product)
- Secondary packaging (outer packaging)
- Tertiary packaging (used for transport and storage)
Artwork is not just design, it is a regulated component of the product itself.
Step-by-Step Packaging Artwork Approval Process
A structured, step-by-step artwork approval workflow is the foundation of compliant labeling operations in pharma and medical devices.
1. Briefing & Artwork Request
Define product requirements, regulatory needs, and collect approved source content (SmPC, IFU, label text).
2. Artwork Creation & Design
Design teams create packaging layouts using templates, branding, and regulatory elements.
3. Internal Review (Cross-functional)
Multiple stakeholders review the artwork:
- Regulatory Affairs (RA): compliance
- Medical: scientific accuracy
- Marketing: branding
- Quality Assurance (QA): process control
4. Text & Artwork Verification
Compare approved source content against artwork to detect:
- Missing or incorrect text
- Errors in dosage, units, or warnings
- Layout and formatting changes
5. External / Affiliate Review
Local teams validate translations, regional requirements, and market-specific compliance.
6. Final QA Approval
Quality Assurance performs final checks and provides formal approval according to GMP standards.
7. Print Proof & Pre-Production Check
Approved artwork is compared against printer proofs to ensure no deviations before production.
8. Release & Archiving
Final artwork is stored with full audit trail, version control, and compliance documentation.
Why artwork approval is critical for safety and compliance
In pharmaceutical products, labeling and packaging artwork provides essential information for patients and healthcare professionals.
This includes:
- Patient Information Leaflets (PIL)
- Instructions for Use (IFU)
- Safety warnings, dosage, and regulatory content
Artwork is also part of regulatory submissions and must meet strict requirements. Any error can lead to:
- Misinterpretation of medical information
- Regulatory delays
- Product recalls
With the rise of e-labeling, this responsibility now extends to digital formats as well.
Artwork requirements for medical devices
For medical devices, artwork and labeling must comply with strict regulatory standards.
According to FDA Quality System Regulation (QSR), labeling includes:
- Equipment labels
- Packaging labels
- Instructions for use
- Maintenance manuals
- Digital interface instructions
Failure to meet these requirements can result in a product being classified as misbranded, leading to compliance risks and potential market withdrawal.
Who is involved in the artwork approval process?
Artwork approval is a cross-functional process involving multiple stakeholders:
- Research & Development (R&D)
- Packaging and design teams
- Regulatory Affairs (RA)
- Quality Assurance (QA)
- Production
- Marketing and brand teams
- Legal and compliance
- Medical affairs
- Supply chain / procurement
Depending on the organization, additional roles such as project managers or product owners may coordinate the process.
In most cases, Quality Assurance is responsible for final approval.
Why artwork approval workflows are complex
Artwork approval does not happen in a simple, linear sequence.
Instead:
- Reviews often happen in parallel across teams
- Multiple projects run simultaneously
- Different systems and tools are used across departments
This creates challenges such as:
- Limited visibility
- Version confusion
- Delays in approvals
- Increased risk of errors
Managing this complexity is one of the biggest challenges for regulated industries.
The role of collaboration and system integration
Effective artwork approval depends on strong collaboration and connected systems.
Organizations typically rely on multiple platforms, including:
- ERP (Enterprise Resource Planning)
- RIM (Regulatory Information Management)
- PLM (Product Lifecycle Management)
Without integration between these systems, workflows become fragmented and inefficient.
How TVT supports artwork approval workflows
TVT is designed to support artwork approval by acting as a verification layer within the process.
It allows teams to:
- Compare approved source documents with artwork files
- Detect deviations instantly
- Verify text, layout, and visual elements across formats
TVT supports multiple file types, languages, and document sizes, making it suitable for global, regulated environments.
What you can expect from TVT
Fast turnarounds and parallel approval
Artwork approval turnarounds are faster because text and artwork verification that might manually takes hours can be performed in minutes. If multiple stakeholders are using TVT (e.g. RA and graphics departments), less time is spent waiting, and parallel approval processes are also faster, reducing timelines.
Collaboration
TVT is collaborative. For example, it can be faster to run an initial check on an artwork file centrally (even in a non-native speaking language) before forwarding the file to a local subsidiary for action. Being able to add comments to the file and print it out in PDF format simplifies feedback steps. Annotation and report functions in TVT record of all actions. TVT creates an audit trail in a single report.
Reduced revisions and correction cycles
Manual revision and correction cycles cost time and tie up valuable human resources and skills that can be better used on tasks that are more value-adding than manual verification of artwork and text. Using TVT as an artwork proofing tool helps you get artwork right first time, reducing the amount of time spent on artwork revisions and reducing the number of correction cycles.
Improved version control and feedback
Annotation and report functions in TVT and TVT Artwork provide a comprehensive audit trail throughout the approval process. If for some reason a printer has made a small change post-approval, a document comparison will highlight it immediately.
Reduced risk of non-compliance
TVT has been designed for regulated industries and is used by leading pharmaceutical companies worldwide, and the fact that it is used by regulatory bodies themselves says much about its strengths.
Easy upscaling and integration
TVT can be integrated into any digital workflow, on-premises or cloud-based, and it can handle files of any size. If growth is increasing your workload, time savings from TVT will allow you to take on more work.
Return on Investment
TVT is intuitive and easy to learn, and online training and support means you can benefit from TVT almost immediately. Taking this and the above factors into account, you can expect a fast return on investment (ROI). How much?
Scalable and compliant workflows
TVT integrates into existing digital workflows (cloud or on-premises) and supports growing workloads without increasing risk.
With minimal training required, organizations can quickly achieve:
- Faster turnaround times
- Improved accuracy
- Strong return on investment
FAQ: Artwork Approval Process
Get quick answers to the most common questions about artwork approval, including delays, error reduction, and tools used to improve compliance.
What causes delays in artwork approval?
Delays are typically caused by manual reviews, version confusion, late-stage changes, and lack of workflow visibility.
How do you reduce errors in artwork review?
Errors can be reduced by implementing automated verification tools, like TVT, that compare approved content with artwork and flag discrepancies instantly.
What tools support artwork approval?
Artwork approval is supported by:
- Artwork management systems (e.g., Esko)
- Regulatory systems (e.g., Veeva Vault)
- Verification tools like TVT
What is the biggest risk in artwork approval?
The biggest risk is releasing incorrect labeling, which can lead to recalls, compliance violations, and patient safety issues.
References
1. FDA Labelling Resources For Human Prescription Drugs
2. FDA Quality System Regulation Labeling Requirements
